COVAGUARD
LIVE

Serial Number

88925587

Owner

Covalon Technologies Ltd.

Attorney

Seth A. Rose

Filing Date

May 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

COVAGUARD Trademark

Serial Number: 88925587

COVAGUARD is a trademark filed by Covalon Technologies Ltd. on May 20, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Covalon Technologies Ltd. (15 trademarks)

1660 Tech Avenue, Unit 5
Mississauga, Ontario L4W5S7 , CA

Entity Type: 99

Trademark Details

Filing Date

May 20, 2020

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

Antimicrobial preparations for creating a protective barrier against microorganisms; antimicrobial spray liquid for creating a protective barrier against microorganisms; antimicrobial gel for creating a protective barrier against microorganisms; antimicrobial aerosol for creating a protective barrier against microorganisms; antimicrobial cream for creating a protective barrier against microorganisms; articles impregnated or coated with antimicrobial preparations for creating a protective barrier against microorganisms, namely, tissues and disposable sanitizing wipes, bandages for skin wounds, surgical bandages, medical and surgical dressings, dressings for catheter insertion sites, dressings for chronic ulcerated wounds, dressings for severe burns, adhesion-prevention dressings; antimicrobial adhesives for medical applications, namely, for adhering wound dressings to the skin, for adhering dressings for catheter insertion sites, for securing surgical and medical apparatus to the skin, and for application to medical and surgical devices for localized delivery of active pharmaceutical ingredients; antimicrobial medical adhesives for use in surgery; antimicrobial medical adhesives for binding internal and external tissue and wounds; antimicrobial adhesives for wound dressing; antimicrobial sanitizing sprays for coating hard surfaces including table tops, counter tops, door knobs, doors, chairs for personal use; bone cement for orthopedic purposes; urine drug test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of drugs; urine pregnancy test kits namely pregnancy test kits for home use; saliva drug test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of drugs; saliva alcohol test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol; cholesterol and blood glucose test; In vitro diagnostic accessories

Chemical preparations for use in manufacturing of antimicrobial preparations to prevent against microorganisms on the finished article; chemical surface coating compositions for industrial use, namely, for use in the manufacture of medical, surgical, laboratory and diagnostic test devices and equipment, biomatrices, orthopaedic implants, sutures, catheters, IV lines, and haemodialysis lines; chemical surface coating compositions for industrial use, namely, for use in the manufacture of antimicrobial coatings for medical, surgical, laboratory and diagnostic test devices and equipment, biomatrices, orthopaedic implants, sutures, catheters, IV lines, and haemodialysis lines; chemical surface coating compositions for industrial use, namely, for use in the manufacture of bed sheets, towels of textile, clothing, tents; chemical surface coating compositions for industrial use, namely, for use in the manufacture of textiles; chemical surface coating compositions for industrial use, namely, for use in the manufacture of antimicrobial coatings for textiles; chemical preparations for use in the manufacture of adhesives having a protective barrier against microorganisms

Medical, surgical, and diagnostic test devices for testing for viruses having a protective barrier against microorganisms; Medical, surgical, and diagnostic test devises having a protective barrier against microorganisms, namely, anatomical bandages for joints, compression bandages, elastic bandages, hernia bandages, support bandages, non-invasive ECG and EEG electrodes and leads, implantable electrodes in the nature of a cortical electrodes, defibrillator, pacemaker, and stimulator; reusable surgical instruments; single-use scalpels; forceps for medical use; biopsy needles; syringe needles for medical purposes; needles used for suturing and absorbable and non-absorbable sutures; infusion, brain, coronary, and ventricular cannulas; intra-ocular lenses; enteral feeding pump tubes; tracheal feeding tubes; tubing specifically adapted for use with infusion pumps; nasal gastric tubes; liquid and gas-flow tubes, namely, epidural and spinal catheters; artificial hip implants; artificial maxillo-facial implants; artificial implantable staples in the nature of a medical device; prosthetic joint replacements in the nature of artificial joints; annuloplasty ring; implantable drug deliver, namely, fallopian tube and vas deferens clip and band contraceptive devices; embolization prevention implants in the nature of contraceptive devices; cardiovascular drug delivery patches sold without medication; intracardiac patch prostheses; mammary prostheses; vascular prostheses; infusion ports in the nature of pumps; infusion port catheters; suction catheters; angiography catheters; cardiac catheters; cerebrospinal catheters; hydrocephalic catheters; intravascular catheters; ventricular neurological catheters; vascular perfusion catheters; cardiovascular stents; iliac stents; biliary, intermittent, abscess, and thoracic surgical drains; cerebrospinal surgical drains; carotid artery shunts; blood testing apparatus, namely, blood collection tubes; orthopaedic implants made of artificial materials; sutures; catheters; IV lines and haemodialysis lines in the nature of intravenous tubes for feeding fluids; Masks for use by medical personnel, medical gloves for use by medical personal, medical gowns, surgical gowns, patient examination gowns, hospital scrubs in the nature of pants and tops, all the foregoing impregnated or coated with antimicrobial preparations for creating a protective barrier against microorganisms

Manufacturing process consulting services in the field of how to apply antimicrobial surface coatings and impregnating materials with antimicrobial preparations; manufacturing process consulting services in the field of antimicrobial additives in manufacturing processes; contract manufacturing services applying antimicrobial surface coatings and impregnating materials with antimicrobial preparations; contract materials processing services applying antimicrobial surface coatings and impregnating materials with antimicrobial preparations

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 14, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 17, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 1, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 1, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 1, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 7, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 6, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 6, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 6, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 31, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 20, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 20, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 20, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 5, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 5, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 5, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 8, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 16, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 16, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 16, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 5, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 2, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 2, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 2, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2023 CRFA
ASSIGNED TO LIE
Jan 21, 2023 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 22, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 24, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 24, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
May 24, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 11, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 16, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 16, 2021 GNSL
SUSPENSION LETTER WRITTEN
Aug 16, 2021 CNSL
ASSIGNED TO EXAMINER
Jul 27, 2021 DOCK
ASSIGNED TO EXAMINER
Jun 9, 2021 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 18, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2020 NWOS
NEW APPLICATION ENTERED
May 23, 2020 NWAP